A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants

NCT07146750 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
212
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi